ERBB2 and invasive ductal breast carcinoma: The predominant histological subtype in both groups was invasive ductal carcinoma (92.5% in HER2-positive vs. 90.7% in HER2-negative, p = 0.142), and lymph node involvement rates were comparable (p = 0.294).